Commercially supported CME: my response to Daniel Carlat

Daniel Carlat, M.D., author of the Carlat Psychiatry Blog and the Carlat Psychiatry Report , kindly responded to my criticism of his postings on Medscape's commercially supported CME His reply, a little more ...

Overweight, Obesity, and the Risk of Recurrent Venous Thromboembolism

Background Excess body weight is a risk factor for a first venous thromboembolism.

Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery

Background Orthopedic surgery remains a condition at high risk of venous thromboembolism .

How maternal deaths following cesarean can be reduced

Washington, Aug 5 : Researchers have suggested a medical procedure that can lower the rate of maternal deaths following cesarean delivery.

The Medscape Ob/Gyn & Women's Health RSS Feed Has Moved

Rebuttal to Stossel's 12 June commentary responding to CEJA's Draft Report: "Ethical Guidance for Physicians and the Profession With Respect to Industry Support for Professional Education in Medicine" The ...

The Medscape Cardiology RSS Feed Has Moved

Rebuttal to Stossel's 12 June commentary responding to CEJA's Draft Report: "Ethical Guidance for Physicians and the Profession With Respect to Industry Support for Professional Education in Medicine" The ...

Journal Watch: Patients Unprotected Against Venous Thromboembolism

According to this article: * Over half of hospitalized patients are at risk for venous thromboembolism, but only half of those get adequate prophylaxis.

Rivaroxaban First Novel Oral Anticoagulant To Significantly Reduce...

Results from a pre-specified pooled analysis of three Phase III studies, RECORD1, 2 and 3, were presented at the 20th International Congress on Thrombosis in Athens.

The Medscape Pharmacists RSS Feed Has Moved

Review the challenges that exist in the care of patients with type 2 diabetes, and explore effective strategies to overcome those challenges and successfully integrate injectable agents into patient treatment ...

New England Journal Of Medicine Publishes Results From Two Of The...

Main Category: Cardiovascular / Cardiology Also Included In: Pharma Industry / Biotech Industry Data from two Phase III clinical trials published in the New England Journal of Medicine , demonstrated that the ...